Article
Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.
Breast cancer research and treatment - 1 Apr 2018
Yang Ciyu, Jairam Sowmya, Amoroso Kimberly A, Robson Mark E, Walsh Michael F, Zhang Liying
Abstract excerpt
PURPOSE: Germline mutations in BRCA1 and BRCA2 confer a significant increase in risk for cancer, and determining pathogenicity of a BRCA variant can guide the clinical management of the disease. About 1/3 of BRCA1 variants reported in the public databases have uncertain clinical significance due to lack of conclusive evidence. This study aims to characterize a novel BRCA1 deletion affecting the + 4 splice donor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
